Skip to content
healthcare.dev

hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Phosphasal]

RxNorm concept 1047791, branded drug (sbd). Prescribable name: Phosphasal 81.6 MG / 40.8 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet.

RxCUI
1047791
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1047791 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Phosphasal (hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet

Related concepts

Linked data

NDCs

  • 00076090201

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1047791 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1047791 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1047791. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.